Search results
Clinical trial diversity is a balancing act of time, quality, and money
Clinical Trials Arena· 6 days agoAnd from a financial perspective, the longer the patient stays on your drug, the more money you will...
Benefit of Eisai and Biogen's Alzheimer's drug increases over time, studies suggest - ET HealthWorld...
The Economic Times· 2 days agoChicago: The benefit of Eisai and Biogen's Alzheimer's drug Leqembi in patients with early-stage...
EU medicines regulator rejects Eisai-Biogen Alzheimer's drug - ET HealthWorld | Pharma
The Economic Times· 6 days agoLondon: The European Union's drugs regulator on Friday rejected Eisai and Biogen's breakthrough...
World Street | OpenAI unveils SearchGPT; Ford tumbles 18%; Rupert Murdoch succession battle; South...
CNBC Awaaz· 7 days agoFrom OpenAI’s new search engine and Ford’s stock plunge to Rupert Murdoch’s succession battle and...
Holcomb using final days in office to strengthen partnerships with international companies
Indiana Capital Chronicle· 3 days agoSpeaking to reporters over Zoom from Singapore — a stop on his latest international economic...
European committee says Alzheimer's treatment Leqembi shouldn't get marketing approval - Times of...
The Times of India· 6 days agoShares of Biogen slid Friday after a European regulatory committee said the Alzheimer's treatment...
Almost Half of Dementia Cases Can Be Fended Off, Study Says
Livemint· 21 hours agoAlmost half of dementia cases can be prevented or delayed by addressing health issues such as vision and hearing loss along with depression, researchers said, offering potential relief as cases ...
Blood tests for Alzheimer's may be coming to your doctor's office. Here's what to know - ET...
The Economic Times· 4 days agoWashington: New blood tests could help doctors diagnose Alzheimer's disease faster and more...
Groundbreaking Blood Test Could Hold Key to Diagnosing Alzheimer’s Disease Faster And More...
Times Now· 4 days agoA new variety of blood tests could easily help doctors diagnose Alzheimer’s disease faster and more...
Patients push back against Novo Nordisk move to scrap an insulin product - ET HealthWorld | Pharma
The Economic Times· 2 days agoLondon: Novo Nordisk's decision to stop selling its long-acting insulin Levemir in the United States...